ReviewJournal of inflammation research2013

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis.

Maurizio Cutolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.